Fund shareholders of Bridgebio Pharma Inc
ISIN US10806X1028 · United States · LEI 54930028YG89VTY2J114
- Fund shareholders
- 445
- Of which ETFs
- 90 355 other funds
- Value held
- ≈ 4.8B $ 4.8B $ · 330.7M SEK · 167.2K €
- Share of capital
- 33.0 % of 195.5M shares on Aug 3, 2026
445 funds hold this company. This table lists the 444 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Health Care Fund Rydex Variable Trust | 722 | 53.8K $ | 0.51 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 703 | 46.6K $ | 0.15 % | 0.00 % | as of May 31, 2026 ↗ |
| Strategic Allocation: Aggressive Fund American Century Strategic Asset Allocations Inc | 700 | 56.1K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 700 | 52.1K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Pacer WealthShield ETF Pacer Funds Trust | 684 | 54.8K $ | 0.23 % | 0.00 % | as of Jul 31, 2026 ↗ |
| SA U.S. Core Market Fund SA FUNDS INVESTMENT TRUST | 679 | 50.6K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Multifactor U.S. Equity Fund RUSSELL INVESTMENT CO | 647 | 51.8K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 625 | 46.6K $ | 0.18 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 572 | 37.9K $ | 0.36 % | 0.00 % | as of May 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 535 | 42.8K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| EQ/Large Cap Value Managed Volatility Portfolio EQ Advisors Trust | 511 | 38.1K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Flex Mid Cap Focused Index Fund Fidelity Salem Street Trust | 488 | 39.1K $ | 0.20 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Virtus Silvant Small/Mid Growth ETF Virtus ETF Trust II | 473 | 37.9K $ | 1.19 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 426 | 34.1K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Motley Fool Momentum Factor ETF RBB Fund, Inc. | 365 | 24.2K $ | 0.21 % | 0.00 % | as of May 31, 2026 ↗ |
| Virtus AlphaSimplex Global Alternatives Fund Virtus Alternative Solutions Trust | 359 | 26.7K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Hartford Equity Premium Income ETF Hartford Funds Exchange-Traded Trust | 300 | 24K $ | 0.07 % | 0.00 % | as of Jul 31, 2026 ↗ |
| EQ/Large Cap Value Index Portfolio EQ Advisors Trust | 284 | 21.2K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Polen 5Perspectives Small-Mid Growth ETF FundVantage Trust | 272 | 21.8K $ | 0.84 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Schwab U.S. Large-Cap Value Index Fund SCHWAB CAPITAL TRUST | 265 | 21.2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 258 | 20.7K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 241 | 17.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| MidCap Value Fund I Principal Funds, Inc | 240 | 19.2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 218 | 16.2K $ | 0.09 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Founders 100 ETF Founder Funds Trust | 208 | 15.5K $ | 0.31 % | 0.00 % | as of Jun 30, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 207 | 15.4K $ | 0.17 % | 0.00 % | as of Jun 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 205 | 16.4K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 200 | 14.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 179 | 11.9K $ | 0.12 % | 0.00 % | as of May 31, 2026 ↗ |
| 1290 Avantis U.S. Large Cap Growth Fund 1290 Funds | 178 | 14.3K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 175 | 14K $ | 0.01 % | 0.00 % | as of Jul 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 172 | 12.8K $ | 0.48 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 148 | 9.8K $ | 0.05 % | 0.00 % | as of May 31, 2026 ↗ |
| Corgi Bay Area Based ETF Corgi ETF Trust I | 140 | 10.4K $ | 0.51 % | 0.00 % | as of Jun 30, 2026 ↗ |
| MoA Large Cap Value Index Fund MoA Funds Corp | 92 | 6.9K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Value ETF Columbia ETF Trust I | 83 | 6.6K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 79 | 5.9K $ | 0.10 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SA Multi-Managed Mid Cap Value Portfolio SEASONS SERIES TRUST | 60 | 4.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Sector Rotation Fund Meeder Funds | 59 | 4.4K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 47 | 3.1K $ | 0.27 % | 0.00 % | as of May 31, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 40 | 3K $ | 0.09 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) Russell 1000 Momentum Focus ETF SPDR SERIES TRUST | 39 | 2.9K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 6 | 397.6 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 167.2K € | 1.28 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.71 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 5.75 % | as of Mar 31, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 3.50 % | as of Jun 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 2.75 % | as of May 31, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 2.59 % | as of May 31, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 2.26 % | as of Jul 31, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund Janus Investment Fund | 2.04 % | as of Jun 30, 2026 ↗ |
| Lord Abbett Health Care Fund LORD ABBETT SECURITIES TRUST | 1.84 % | as of Jul 31, 2026 ↗ |
| DWS Global Small Cap Fund DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. | 1.83 % | as of Jul 31, 2026 ↗ |
| AMG GW&K Small Cap Growth Fund AMG Funds IV | 1.83 % | as of Jul 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 1.82 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 438 | -10 | 64,023,707 | -6.4 % |
| 2026Q2 | 448 | +35 | 68,423,703 | +4.7 % |
| 2026Q1 | 413 | +58 | 65,336,428 | +9.0 % |
| 2025Q4 | 355 | +35 | 59,967,793 | +4.5 % |
| 2025Q3 | 320 | +41 | 57,383,094 | +13.0 % |
| 2025Q2 | 279 | +44 | 50,770,124 | +7.7 % |
| 2025Q1 | 235 | -11 | 47,152,884 | +8.5 % |
| 2024Q4 | 246 | -24 | 43,448,131 | +2.9 % |
| 2024Q3 | 270 | -6 | 42,238,206 | +3.2 % |
| 2024Q2 | 276 | +15 | 40,932,145 | +1.2 % |
| 2024Q1 | 261 | +33 | 40,458,314 | +18.0 % |
| 2023Q4 | 228 | 34,283,131 |
Institutional managers
449 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 14,207,757 | 1.1B $ | as of Mar 31, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | 984.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 13,179,013 | 978.6M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 11,842,434 | 879.4M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 9,365,463 | 695.5M $ | as of Mar 31, 2026 |
| Aisling Capital Management LP | 5,089,611 | 378M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,934,320 | 366.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,918,030 | 371.9M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 4,592,814 | 341.1M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,801,655 | 282.3K $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 3,448,139 | 256.1M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 3,173,940 | 235.7M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,120,631 | 231.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,545,486 | 189M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 2,519,306 | 187.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,483,953 | 184.5M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,438,925 | 181.1M $ | as of Mar 31, 2026 |
| FMR LLC | 2,343,754 | 174M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,026,821 | 150.5M $ | as of Mar 31, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1,977,080 | 146.8M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,976,094 | 146.7M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,908,907 | 146M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,897,716 | 140.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,877,359 | 139.4M $ | as of Mar 31, 2026 |
| SC US (TTGP), LTD. | 1,860,364 | 138.2M $ | as of Mar 31, 2026 |
Declared shareholders of Bridgebio Pharma Inc
There are 4 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Farallon Capital Management, L.L.C. and 28 others | 5.50 % | 10,743,063 | as of Jun 30, 2026 · SCHEDULE 13G |
| VIKING GLOBAL INVESTORS LP and 6 others | 5.00 % | 9,792,219 | as of Jul 9, 2026 · SCHEDULE 13D |
| BlackRock, Inc. | 4.96 % | 9,733,762 | as of Jun 30, 2026 · SCHEDULE 13G |
| KKR Genetic Disorder L.P. and 8 others | 4.70 % | 9,232,739 | as of Aug 13, 2026 · SCHEDULE 13D |
Funds holding the debt of Bridgebio Pharma Inc
58 funds declare 91 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Bridgebio Pharma Inc". https://titelia.com/en/stocks/bridgebio-pharma-inc-US10806X1028